Damora Therapeutics, Inc. (NASDAQ:DMRA) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jennifer Jarrett Other companies: Sagimet Biosciences Inc. - Series A (Board Member · Since at least Aug 1, 2024); Zura Bio Limited (Director · Since at least Mar 20, 2023); Syndax Pharmaceuticals, Inc. (Director · Since at least Sep 25, 2018); Arcus Biosciences, Inc. (Chief Operating Officer · Since at least Mar 14, 2018); Radius Health, Inc. (Director · May 18, 2022 – Aug 15, 2022 · Past); Surrozen, Inc. (Director · Nov 18, 2020 – Nov 18, 2020 · Past); Arena Pharmaceuticals Inc (Director · Jun 13, 2017 – Mar 11, 2022 · Past); Audentes Therapeutics Inc (Director · Jun 12, 2017 – Jan 15, 2020 · Past); Medivation Inc (Chief Financial Officer · Apr 7, 2016 – Sep 28, 2016 · Past) | President and Chief Executive Officer in March 2026, Board Director · Since at least Mar 30, 2026 |
| Peter Harwin Other companies: Crescent Biopharma, Inc. (Chair of Board · Since at least Jun 13, 2025); Jade Biosciences, Inc. (Director · Since at least Apr 28, 2025); Zenas BioPharma, Inc. (Director · Since at least Sep 12, 2024); Oruka Therapeutics, Inc. (Director · Since at least Aug 29, 2024); Apogee Therapeutics, Inc. (Director · Since at least Jul 13, 2023); Spyre Therapeutics, Inc. (Director · Since at least Jun 22, 2023); Cogent Biosciences, Inc. (Founding Partner, Fairmount Funds Management LLC · Since at least Jul 6, 2020); Dianthus Therapeutics, Inc. (Director · Sep 11, 2023 – Jan 22, 2024 · Past); Viridian Therapeutics, Inc. (Director · Oct 27, 2020 – Jun 26, 2024 · Past) | Chairman of the Board · Since at least Nov 10, 2025 |
| Chau Quang Khuong Other companies: Fusion Pharmaceuticals Inc (Director · Jun 25, 2020 – Jun 14, 2023 · Past); Whitehawk Therapeutics, Inc. (Director · Jun 18, 2019 – Jun 18, 2019 · Past); Synlogic Inc (Director · Jun 5, 2019 – Apr 20, 2021 · Past); NextCure, Inc. (Director · May 8, 2019 – Jun 22, 2023 · Past); Inspire Medical Systems, Inc. (Director · Apr 10, 2019 – Oct 9, 2020 · Past) | Director · Oct 28, 2020 – Jun 14, 2023 · Past |
| Andrew Cheng Other companies: TCGX Acquisition Corp. (Director · Since at least Aug 4, 2026); Vera Therapeutics, Inc. (Director · Since at least May 13, 2021); Akero Therapeutics Inc (President and CEO, Director · Since at least Jun 19, 2019); Arbutus Biopharma Corporation (Director · Aug 17, 2019 – Jun 3, 2021 · Past) | Board Director · Since at least Aug 10, 2026 |
| Cameron Turtle Other companies: Oruka Therapeutics, Inc. (Director · Since at least Aug 29, 2024); Spyre Therapeutics, Inc. (Chief Executive Officer · Since at least Jun 22, 2023); BridgeBio Pharma, Inc. (See Remarks · Jun 27, 2019 – Dec 28, 2020 · Past); Eidos Therapeutics Inc (Chief Business Officer · Nov 5, 2018 – Jan 26, 2021 · Past) | Board Director · Since at least Mar 23, 2026 |
| Anne Prener Other companies: Keros Therapeutics, Inc. (Director · Since at least Jun 25, 2026); Kaleido Biosciences, Inc. (Director · Jun 30, 2021 – Jun 30, 2021 · Past); Rubius Therapeutics Inc (Director · May 12, 2021 – May 12, 2022 · Past) | Director · Since at least Jan 8, 2021 |
| Chris Cain Other companies: Jade Biosciences, Inc. (Director · Since at least Apr 28, 2025); Viridian Therapeutics, Inc. (Director · Since at least Mar 10, 2025); Cogent Biosciences, Inc. (Director · Since at least Jul 6, 2020) | Board Director · Since at least Nov 10, 2025 |
| Jayson Donald Alexander Dallas Other companies: Aimmune Therapeutics Inc (President and CEO, Director · Jun 19, 2018 – Oct 10, 2020 · Past); Arena Pharmaceuticals Inc (Director · Feb 13, 2017 – Mar 11, 2022 · Past); Ultragenyx Pharmaceutical Inc. (EVP & Chief Commercial Officer · Aug 3, 2015 – Jun 1, 2018 · Past) | Director · Since at least Nov 19, 2020 |
| Amy B. Wechsler Other companies: Bausch Health Companies Inc. (Director · Since at least Sep 30, 2020) | Director · Since at least Oct 11, 2024 |
| Becker Hewes Other companies: Blueprint Medicines Corp (Chief Medical Officer · Since at least Jan 11, 2021) | Chief Medical Officer · Since at least Jan 5, 2026 |
| Brian Burkavage Other companies: Passage Bio, Inc. (Controller · May 30, 2021 – May 30, 2021 · Past) | Senior Vice President, Finance · Since at least May 1, 2026 |
| David Shapiro Other companies: Design Therapeutics, Inc. (Director · Since at least Mar 31, 2026) | Director · Since at least Oct 28, 2020 |
| Garrett Winslow Other companies: Spring Bank Pharmaceuticals Inc (General Counsel and Secretary · Mar 5, 2020 – Mar 5, 2020 · Past) | General Counsel · Since at least May 3, 2021 |
| Jonathan Freve Other companies: Spring Bank Pharmaceuticals Inc (CFO & Treasurer · May 5, 2016 – Mar 5, 2020 · Past) | Chief Financial Officer · Oct 28, 2020 – Jan 3, 2024 · Past |
| Lori Firmani Other companies: Spring Bank Pharmaceuticals Inc (VP of Finance and Treasurer · Apr 24, 2020 – Apr 24, 2020 · Past) | Chief Financial Officer · Since at least Aug 12, 2024 |
| Michael Landsittel Other companies: Blueprint Medicines Corp (Chief Financial Officer · Since at least Aug 11, 2015) | Director · Since at least Mar 23, 2026 |
| Anders Pedersen | Chief Operating Officer · Oct 28, 2020 – Jan 4, 2023 · Past |
| Bertil Lindmark | Chief Medical Officer · Oct 28, 2020 – Jan 4, 2023 · Past |
| Hans T Schambye | Chief Executive Officer, Director · Since at least Oct 28, 2020 |
| Jim Baker | Chief Corporate Affairs Officer · Since at least Oct 5, 2026 |
| Julianne Bruno | Director · Since at least Nov 10, 2025 |
| Matthew Kronmiller | EVP Strategy and CBO · Oct 7, 2024 – Jan 3, 2025 · Past |
| Michael Landsittel | Board Director · Since at least Nov 5, 2026 |
| Sherwin Sattarzadeh | Chief Operating Officer · Since at least Jan 5, 2026 |
| Soren Moller | Director · Oct 28, 2020 – Oct 28, 2020 · Past |
| Stephanie Oestreich | Chief Business Officer · Jan 5, 2022 – Jan 4, 2023 · Past |